Found 4 matching trials
A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy PHASE3 This study is researching 2 experimental drugs, REGN5713 and REGN5715, whic...
Show More Location
Andover Eye Associates
Learn More & Join Trial
Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants PHASE2 Primary objective: To assess the efficacy of a single dose of the anti- Bet...
Show More Location
Kingston General Health Research Institute
Learn More & Join Trial
Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy PHASE3 This study is researching 2 experimental drugs, REGN5713 and REGN5715. The ...
Show More Location
Andover Eye Associates
Learn More & Join Trial
Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis PHASE3 The primary objective is to assess the reduction of allergic symptoms as me...
Show More Location
Regeneron Study Site
Learn More & Join Trial